维普中文期刊产品整合服务
19篇 您的检索式:作者名="Mrdovic"
    题名 作者 年代 出处 被引量
1Sex-related analysis of shortand long-term clinical outcomes and bleeding among patients treated with primary percutaneous coronary intervention:an evaluation of the RISK-PCI data显示文摘Mrdovic I Savic L Asanin M 2013Can J Cardiol2013,29,9:1
2Prognostic significance of new atrial fibrillation and its relation to heart failure following acute myocardial infarction显示文摘Asanin M Perunicic J Mrdovic I 2005Eur J Heart Fail2005,21,7:1
3Rationale and design of the on- treatment PLAtelet Reactivity-Guided Therapy Modification FOR ST- Segment Elevation Myocardial Infarction ( PLATFORM ) randomized trial 显示文摘Mrdovic I Savic L Krljanac G etal 2013J Interv Cardiol2013,26,3:1
4Significance of recurrences of new atrial fibrillation in acute myocardial infarction 显示文摘ASANIN M PERUNICIC J MRDOVIC I 2005Int J Cardiol2005,102,1:1
5Prognostic significance of the occulTence of acute heart failure after successful primary pe reutane- ous coronary intervention显示文摘Savic L Mrdovic I Peranieic J 2010J lnvasive Cardiol2010,22,7:1
6Simple risk algo- rithm to predict serious bleeding in patients with ST- segment elevation myocardial infarction undergoing pri- mary pereutaneous coronary intervention: RISK-PCI bleeding score显示文摘Mrdovic I Savic L Krljanac G 2013Cire J2013,77,7:1
7B-type natriuretic pep- tide predicts new-onset atrial fibrillation in patients with ST-seg- ment elevation myocardial infarction treated by primary percuta-显示文摘Asanin M Stankovic S Mrdovic I 2012Peptides2012,35,1:1
8B-type natriuretic peptide predicts new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention显示文摘Asanin M Stankovic S Mrdovic I 2012Peptides2012,,1:1
9B-type natriuretic peptide predicts new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention显示文摘ASANIN M STANKOVIC S MRDOVIC I 2012Peptides2012,35,1:1
10Prognostic significance of the occur- rence of acute heart failure after successful primary percutaneous coronary intervention 显示文摘Savic L Mrdovic I Perunicic J 2010The Journal of Invasive Cardiology2010,21,07:1
11Efficacy and safetyof tirofiban-supported primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: results of propen- sity analysis using the Clinical Center of SerbiaSTEMI Register 显示文摘MRDOVIC I SAVIC L LASICA R 2014Eur Heart J Acute Cardiovasc Care2014,3,1:1
12Myocardial reinfarction in a patient with coronary ectasia显示文摘Mrdovic I Jozic T Asanin M 2004Cardiology2004,102,1:1
13Prognostic significance of the occurrence of acute heart failure after suc- cessful primary percutaneous coronary intervention显示文摘Savic L Mrdovic I Perunicic J 2010The Journal of Invasive Cardiology2010,22,7:1
14Rationale and design of the on-treatment PLAtelet Reactivity-Guided Therapy Modification FOR ST-Segment Elevation Myocardial Infarction (PLATFORM) randomized trial显示文摘Mrdovic I Savic L Krljanac G 2013J Interv Cardiol2013,26,3:1
15High-dose streptokinase in the treatment of acute massive pulmonary embolism complicated with cardiogenic shock,respiratory arrest and ventricular fibrillation显示文摘LASICA R PERUNICIC J MRDOVIC I 2005Vojnosanit Pregl2005,62,78:1
16B-type natriuretic peptide predicts new- onset atrial fibrillation in patients with ST-segment elevation myocardial infarc- tion treated by nimac percutaneous coronaw inteention 显示文摘Asanin M Stankovie S Mrdovic I 2012Peptides2012,35,1:1
17Prognostic significance of new atrial fibrillation and its relation to heart failure following acute myocardial infarction显示文摘Asanin M Perunicic J Mrdovic I 0,,04:1
18Efficacy and safety of tirofiban -supported primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel : results of propensity analysis using the Clinical Center of Serbia STEMI Register 显示文摘Mrdovic I Savic L Lasica R 2014Eur Heart J Acute Cardiovasc Care2014,3,1:1
19急性心肌梗死后左室功能不全患者中卡维地洛与美托洛尔治疗比较:一项随机、阳性药物对照研究显示文摘背景:先前的研究证实,卡维地洛对于急性心肌梗死(AMI)伴左室(LV)功能不全的患者有益。但是,迄今为止,尚未在此类人群中对美托洛尔进行随机评估。Mrdovic I.B. Savic L.Z. Perunicic J.P. 黄欣 2007世界核心医学期刊文摘(心脏病学分册)2007,,10:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费